iohexol has been researched along with Ehlers-Danlos Syndrome in 1 studies
Iohexol: An effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality.
iohexol : A benzenedicarboxamide compound having N-(2,3-dihydroxypropyl)carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and an N-(2,3-dihydroxypropyl)acetamido group at the 5-position.
Ehlers-Danlos Syndrome: A heterogeneous group of autosomally inherited COLLAGEN DISEASES caused by defects in the synthesis or structure of FIBRILLAR COLLAGEN. There are numerous subtypes: classical, hypermobility, vascular, and others. Common clinical features include hyperextensible skin and joints, skin fragility and reduced wound healing capability.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chu, LC | 1 |
Johnson, PT | 1 |
Dietz, HC | 1 |
Brooke, BS | 1 |
Arnaoutakis, GJ | 1 |
Black, JH | 1 |
Fishman, EK | 1 |
1 other study available for iohexol and Ehlers-Danlos Syndrome
Article | Year |
---|---|
Vascular complications of Ehlers-Danlos syndrome: CT findings.
Topics: Adolescent; Adult; Angiography; Angiography, Digital Subtraction; Contrast Media; Ehlers-Danlos Synd | 2012 |